Biomerica to present at the 18th Annual B. Riley & Co. investor conference on May 24, 2017
Irvine, Calif. -- May 23, 2017 --
Biomerica Inc. (Nasdaq: BMRA) today announced it will present at the 18th Annual B. Riley institutional investor conference being held May 24-25, 2017 in Santa Monica, CA.
Zackary Irani, Chief Executive Officer of Biomerica, will present a business update about its InFoods IBS (Irritable Bowel Syndrome) product.
The Biomerica InFoods IBS product identifies patient specific foods that when removed may alleviate an individual's IBS symptoms. This patent-pending, diagnostic-guided therapy is designed to allow for a patient specific, guided dietary regimen to improve Irritable Bowel Syndrome (IBS) outcomes.
Event: 18th Annual B. Riley institutional investor conference
Date: Weds, May 24, 2017
Time: 1:30 p.m. PST
Location: Lowes Santa Monica Beach Hotel
The presentation is available by clicking the following link www.biomerica.com/news/investor.pdf.